INLB.US Item 9 Labs Corp

Healthcare Pharmaceuticals USA Stocks
0.0001 USD
Close of Jan 26, 2026
0.0001 0.0001
Market cap
USD 10.2K
P/E
-
P/B
0.00x
ROE
-31.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2023.

Is INLB.US undervalued?

Graham number

The Graham number of Item 9 Labs Corp cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Item 9 Labs Corp fundamental analysis

No fundamental analysis for Item 9 Labs Corp yet.

Item 9 Labs Corp stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Item 9 Labs Corp

Item 9 Labs Corp. operates as a vertically integrated cannabis operator and dispensary franchisor in the United States. It operates through Cultivation, Franchising, and Corporate segments. The company produces cannabis and cannabis-related products in various categories, such as flower; concentrates; distillates; and hardware. It offers cannabis and cannabis-derived products and technologies through licensed dispensaries to consumers in Arizona. It also operates and sells m…

Full company profile